Cosmos Health (COSM) closed at $0.28 on October 21, 2026, down 15.2% from the previous close, on volume of 2,632,763 shares (30-day average 3,346,477).
Data as of October 21, 2026.
ACCESS Newswire (Tue, 20-Oct 12:15 PM ET)
ACCESS Newswire (Mon, 19-Oct 9:30 AM ET)
ACCESS Newswire (Wed, 14-Oct 9:30 AM ET)
ACCESS Newswire (Tue, 13-Oct 9:30 AM ET)
ACCESS Newswire (Wed, 7-Oct 9:34 AM ET)
ACCESS Newswire (Thu, 1-Oct 3:58 PM ET)
ACCESS Newswire (Tue, 29-Sep 9:30 AM ET)
ACCESS Newswire (Mon, 28-Sep 8:00 AM ET)
ACCESS Newswire (Tue, 15-Sep 10:30 AM ET)
ACCESS Newswire (Mon, 14-Sep 3:59 PM ET)
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
Cosmos Health trades on the NASDAQ stock market under the symbol COSM.
As of October 22, 2026, COSM stock price declined to $0.27 with 837,156 million shares trading.
COSM has a beta of 2.53, meaning it tends to be more sensitive to market movements. COSM has a correlation of 0.11 to the broad based SPY ETF.
COSM has a market cap of $27.17 million. This is considered a Sub-Micro Cap stock.
Last quarter Cosmos Health reported $19 million in Revenue and -$.10 earnings per share. This fell short of revenue expectation by $-434,136 and missed earnings estimates by -$.11.
In the last 3 years, COSM traded as high as $1.65 and as low as $.16.
The top ETF exchange traded funds that COSM belongs to (by Net Assets): VXF.
COSM has underperformed the market in the last year with a price return of -74.3% while the SPY ETF gained +14.7%. However, in the short term, COSM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +28.9% vs +2.1% return in SPY. But in the last 2 weeks, COSM shares have been beat by the market, returning -15.9% compared to an SPY return of -1.9%.
COSM support price is $.26 and resistance is $.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COSM shares will trade within this expected range on the day.
